|
| |
Image Results
Loading...
Loading...
L.F Will Co Pharmaceutical Company Pages on BioPortfolio:
|
Antibody By Gene - T
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug .... hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor ...
http://www.bioportfolio.co.uk/antibody/genes-T.htm...
|
BioPortfolio - Myopia
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life ... *MD daggerBS Department of Ophthalmology (MJ, LS, LF, WX, TQ), and, Optom Vis Sci.
... Companies working in the area of Myopia from Bioportfolio's Biocorporate
database : ... the public sector healthcare network to spearhead and co-ordinate
the. ...
http://www.bioportfolio.com/indepth/Myopia.html...
|
BioPortfolio - Insulinoma
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ... LF UK a VFN, U Nemocnice 1, 128 08 Praha 2. Cas Lek Cesk.
2009;148(8):389-94. ... Promote your company here: BioNewsCast - Press Release
Distribution ... 7557251, Production of gossypol co-crystals ...
http://www.bioportfolio.com/indepth/Insulinoma.html...
|
BioPortfolio - Filariasis - InDepth
28 Oct 2009 ... Global Public Policy and Corporate Responsibility, Merck & Co., Inc, One- Ann Trop Med Parasitol. ... Lucknow district was endemic for lymphatic filariasis (
LF). ... formulation and pharmaceutical applications thereof ...
http://www.bioportfolio.com/indepth/Filariasis.pdf...
|
BioPortfolio - Gastrointestinal Digestive - InDepth
Devices for the treatment of obesity: will understanding the physiology of satiety unravel new targets for ... 6055447- Patient CO.sub.2 Measurement ...
7375080- Immobilized lactoferrin (Im-LF) antimicrobial agents and uses thereof
... 7037889- Pharmaceutical compositions for sustained drug delivery ...
http://www.bioportfolio.com/indepth/Gastrointestinal_Digesti...
|
BioPortfolio - Insulinoma - InDepth
LF UK a VFN, U Nemocnice 1, 128 08 Praha 2.- Cas Lek Cesk. 2009;148(8):389-94. ... Research Institute of Pharmaceutical Sciences, Musashino University,- Cell
Struct Funct. ... 7557251- Production of gossypol co-crystals ...
http://www.bioportfolio.com/indepth/Insulinoma.pdf...
| Results from other life science and pharmaceutical sites:
LF Elimination programme treats over half billion people and ...
8 Oct 2008 ... “Future public-private partnerships will look to the global LF elimination effort as a ... In 1998, two pharmaceutical companies – GlaxoSmithKline (then
SmithKline Beecham) and Merck & Co., Inc. – partnered with WHO and ...
http://www.gsk.com/media/pressreleases/2008/2008_pressreleas...
|
The Global Programme to Eliminate Lymphatic Filariasis: Health ...
... pledges from two pharmaceutical companies (GlaxoSmithKline and Merck & Co., ..... Since MDAs, by decreasing and then stopping LF transmission, will ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556399/...
|
New data in Lancet confirm potential to eliminate lymphatic filariasis
24 Mar 2006 ... The Global Alliance to Eliminate LF was formed with the support of the pharmaceutical companies ... The Global Alliance to Eliminate LF will meet in
Fiji next week where the future ... private sector companies, international
development agencies and ... For Africa, Mectizan®, donated by Merck & Co. ...
http://www.gsk.com/media/pressreleases/2006/2006_03_24_GSK77...
|
Layout 4 copy
industry, it has served as a model for pharmaceutical companies who have established similar programs. ... elimination of LF in African countries where
it co-exists .... integrity of purpose; provides assurance that Merck products
will ...
http://www.merck.com/corporate-responsibility/docs/mmop_broc...
|
GlaxoSmithKline and The Carter Center reaffirm commitment to ...
The donation to The Carter Center will help enable a two-year initiative to scale up ... A clear example of the company's long-term commitment, the Global
Program to Eliminate LF relies ... respectively) – from GlaxoSmithKline and
Merck & Co., ... drug donation program ever supported by the pharmaceutical
industry. ...
http://www.gsk.com/media/pressreleases/2008/2008_us_pressrel...
|
Conversations with our Partners
24 Oct 2008 ... Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated ... the number of local program sites and will be on track toward at ... LF: The
Merck Company Foundation has been The Albert Schweitzer ...
http://www.merck.com/corporate-responsibility/philanthropy/c...
|
Facing the Challenge
As a leading international pharmaceutical company we can make a real ..... offer will apply to all Least Developed Countries and all countries of ..... to the
countries of Sub-Saharan Africa where LF and river blindness co-exist. ...
http://www.gsk.com/community/downloads/facing_the_challenge....
|
Draft remarks for Ken Frazier
Merck & Co., Inc. Ben Franklin Award. January 16, 2009 ... Now I will grant you that we did not do so by invoking the words of Benjamin Franklin, but ...
neither Merck nor any major pharmaceutical company had experience in at the time
. One of ... another tropical disease called lymphatic filariasis – or LF. ...
http://www.merck.com/corporate-responsibility/docs/ben_frank...
|
GLOBAL PROGRAMME TO ELIMINATE LYMPHATIC FILARIASIS: HEALTH IMPACT ...
o WHO received extraordinary pledges from two pharmaceutical companies ( GlaxoSmithKline and Merck ... o Nearly 600 million tablets of Mectizan® by Merck
& Co., Inc ... 10‐fold reduction of micro filarial (life stage of LF)‐prevalence
in ...
http://www.gsk.com/filariasis/downloads/LF-Impact-summary.pd...
|
Schistosomiasis in Africa: An Emerging Tragedy in Our New Global ...
With the active involvement of global partnerships for LF and onchocerciasis, ... together with ongoing donations from GlaxoSmithKline and Merck & Co., ...
there is great optimism that coverage for these conditions will continue to ...
a generic pharmaceutical company that utilizes donations from Canadian citizens.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746322/...
|
|
